READAPTATION TO THE SLEEP LABORATORY IN INSOMMIAC SUBJECTS.SCHARF MB; KALES A; BIXLER EO et al.1975; PSYCHOPHYSIOLOGY; U.S.A.; DA. 1975; VOL. 12; NO 14; PP. 412-415; BIBL. 6 REF.Article

HYPNOTIC EFFECTIVENESS OF SODIUM SALICYLAMIDE WITH SHORT-TERM USE: SLEEP LABORATORY STUDIES.SOLDATOS CR; KALES A; BIXLER EO et al.1978; PHARMACOLOGY; SWITZ.; DA. 1978; VOL. 16; NO 4; PP. 193-198; BIBL. 17 REF.Article

COMPARATIVE EFFECTIVENESS OF NINE HYPNOTIC DRUGS: SLEEP LABORATORY STUDIES.KALES A; BIXLER EO; KALES JD et al.1977; J. CLIN. PHARMACOL.; U.S.A.; DA. 1977; VOL. 17; NO 4; PP. 207-213; BIBL. 10 REF.Article

EFFECTIVENESS OF INTERMEDIATE-TERM USE OF SECOBARBITAL.KALES A; HAURI P; BIXLER EO et al.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 20; NO 5; PP. 541-545; BIBL. 12 REF.Article

SLEEP LABORATORY STUDIES OF FLURAZEPAM: A MODEL FOR EVALUATING HYPNOTIC DRUGSKALES A; BIXLER EO; SCHARF M et al.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 19; NO 5 PART. 1; PP. 576-583; BIBL. 16 REF.Article

THE EFFECTS OF HYPNOTIC DRUGS ON PERFORMANCEBIXLER EO; KALES A; TJIAUW LING TAN et al.1973; CURR. THERAPEUT. RES.; U.S.A.; DA. 1973; VOL. 15; NO 1; PP. 13-24; BIBL. 15 REF.Serial Issue

HYPNOTIC EFFICACY OF TRIAZOLAM: SLEEP LABORATORY EVALUATION OF INTERMEDIATE TERM EFFECTIVENESS.KALES A; KALES JD; BIXLER EO et al.1976; J. CLIN. PHARMACOL.; U.S.A.; DA. 1976; VOL. 16; NO 8-9; PP. 399-406; BIBL. 14 REF.Article

PSYCHIATRIC SYMPTOMATOLOGY IN AN OUTPATIENT NEUROLOGY CLINICBERLIN RM; RONTHAL M; BIXLER EO et al.1983; JOURNAL OF CLINICAL PSYCHIATRY; ISSN 0160-6689; USA; DA. 1983; VOL. 44; NO 6; SECT. 1; PP. 204-206; BIBL. 11 REF.Article

PREVALENCE OF SLEEP DISORDERS IN THE LOS ANGELES METROPOLITAIN AREABIXLER EO; KALES A; SOLDATOS CR et al.1979; AMER. J. PSYCHIATRY; USA; DA. 1979; VOL. 136; NO 10; PP. 1257-1262; BIBL. 21 REF.Article

EFFECTIVENESS OF HYPNOTIC DRUGS WITH PROLONGED USE: FLURAZEPAN AND PENTOBARBITALKALES A; KALES JD; BIXLER EO et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 3; PP. 356-363; BIBL. 17 REF.Article

EFFECTS OF HYPNOTIC DRUGS ON MEMORYBIXLER EO; SCHARF MB; SOLDATOS CR et al.1979; LIFE SCI.; GBR; DA. 1979; VOL. 25; NO 16; PP. 1379-1388; BIBL. 27 REF.Article

LONG-TERM SLEEP LABORATORY EVALUATION OF FLUNITRAZEPAMSCHARF MB; BIXLER EO; KALES A et al.1979; PHARMACOLOGY; CHE; DA. 1979; VOL. 19; NO 4; PP. 173-181; BIBL. 23 REF.Article

NARCOLEPSY-CATAPLEXY. I: CLINICAL AND ELECTROPHYSIOLOGIC CHARACTERISTICSKALES A; CADIEUX RJ; SOLDATOS CR et al.1982; ARCH. NEUROL. (CHIC.); ISSN 0003-9942; USA; DA. 1982; VOL. 39; NO 3; PP. 164-168; BIBL. 23 REF.Article

ONSET OF INSOMNIA: ROLE OF LIFE-STRESS EVENTSHEALEY ES; KALES A; MONROE LJ et al.1981; PSYCHOSOM. MED.; ISSN 0033-3174; USA; DA. 1981; VOL. 43; NO 5; PP. 439-451; BIBL. 39 REF.Article

QUAZEPAN, A NEW BENZODIAZEPINE HYPNOTIC: INTERMEDIATETERM SLEEP LABORATORY EVALUATIONKALES A; SCHARF MB; SOLDATOS CR et al.1980; J. CLIN. PHARMACOL.; USA; DA. 1980; VOL. 20; NO 4 PART. 1; PP. 184-192; BIBL. 21 REF.Article

SLEEP APNEIC ACTIVITY IN A NORMAL POPULATIONBIXLER EO; KALES A; SOLDATOS CR et al.1982; RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY; ISSN 0034-5164; USA; DA. 1982; VOL. 36; NO 1; PP. 141-152; BIBL. 2 P.Article

EFFECTS OF FLURAZEPAM (DALMANE) ON ANTERIOR PITUITARY SECRETION.BIXLER EO; KALES A; SANTEN R et al.1976; REV. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1976; VOL. 14; NO 3; PP. 421-429; BIBL. 1 P.Article

NARCOLEPSY-CATAPLEXY. II: PSYCHOSOCIAL CONSEQUENCES AND ASSOCIATED PSYCHOPATHOLOGYKALES A; SOLDATOS CR; BIXLER EO et al.1982; ARCH. NEUROL. (CHIC.); ISSN 0003-9942; USA; DA. 1982; VOL. 39; NO 3; PP. 169-171; BIBL. 20 REF.Article

DOSE-RESPONSE STUDIES OF QUAZEPAMKALES A; SCHARF MB; BIXLER EO et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 30; NO 2; PP. 195-200; BIBL. 12 REF.Article

PROPANOLOL IN THE TREATMENT OF NARCOLEPSYKALES A; SOLDATOS CR; CADIEUX R et al.1979; ANN. INTERN. MED.; USA; DA. 1979; VOL. 91; NO 5; PP. 741-743; BIBL. 10 REF.Article